Mylea Charvat PhD

Dr Mylea Charvat became interested in the brain at age 13 when her grandmother began to suffer cognitive problems. A clinician with a business background, she was an early employee with Travelocity in the 1990s & went on to train as a clinical neuropsychologist & neuroscientist & in 2015 founded Savonix. At Savonix, Mylea drives strategy to address dementia globally with business & clinical leaders & works as a domain expert in digital cognitive assessment with partners from Boston University to Fortune 50 CEOs seeking to detect & prevent cognitive decline & dementias.

Mylea has authored several peer-review publications in mental health & neuroimaging. She completed her fellowship in clinical neuroscience at Stanford & has been a lecturer at Stanford, The University of San Francisco & San Francisco State University. She is a contributor for Psychology Today, has written for Tech Crunch & Huffington Post & appeared as a subject matter expert at many conferences including MedTech Showcase, The Atlantic Council, the NIH & NIA & with the Duke Leadership Program.

Mylea is committed to advancing the integration of cognitive health data into mainstream healthcare. The inspiration for Savonix came when her husband was severely injured in an accident & she experienced, first hand, the difficulty in attaining vital health data needed to achieve recovery – including cognitive screening. She realized that if access was difficult for her with all her connections, that it must be virtually nonexistent for most people. She got to know the spouses & parents of other patients. What she learned in these conversations was a wake-up call. With a blossoming career ahead of her in academic medicine, Dr. Charvat left over a decade of work & a prestigious career path toward professorship to found Savonix.